Tumor necrosis factor-α inhibitor-associated psoriasis: Facts and hypotheses

Feng Luo^{1

2}, Yung-Heng Lee^{3

4

5

6}, Wu-Kai Ma^{1

2}, Su-Boon Yong^{7

8}, Xue-Ming Yao^{1

2}, James Cheng-Chung Wei^{7

9

10}

Affiliations

¹ Guizhou University of Traditional Chinese Medicine, Guiyang, China.
² Department of Rheumatology and Immunology, Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
³ Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
⁴ Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.
⁵ Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
⁶ Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
⁷ Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁸ Division of Pediatric Allergy, Immunology, and Rheumatology, Lin-Shin Hospital, Taichung, Taiwan.
⁹ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
¹⁰ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

PMID: 37306678
DOI: 10.1111/1756-185X.14661

Editorial

Tumor necrosis factor-α inhibitor-associated psoriasis: Facts and hypotheses

Feng Luo et al. Int J Rheum Dis. 2023 Jun.

. 2023 Jun;26(6):1011-1014.

doi: 10.1111/1756-185X.14661.

Authors

Feng Luo^{1

2}, Yung-Heng Lee^{3

4

5

6}, Wu-Kai Ma^{1

2}, Su-Boon Yong^{7

8}, Xue-Ming Yao^{1

2}, James Cheng-Chung Wei^{7

9

10}

Affiliations

¹ Guizhou University of Traditional Chinese Medicine, Guiyang, China.
² Department of Rheumatology and Immunology, Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
³ Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
⁴ Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.
⁵ Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
⁶ Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
⁷ Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁸ Division of Pediatric Allergy, Immunology, and Rheumatology, Lin-Shin Hospital, Taichung, Taiwan.
⁹ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
¹⁰ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

PMID: 37306678
DOI: 10.1111/1756-185X.14661

No abstract available

PubMed Disclaimer

Comment on

Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor-α Inhibitor Treatment in Patients With Immune-Mediated Inflammatory Diseases: A Danish Nationwide Cohort Study.
Thein D, Egeberg A, Skov L, Loft N. Thein D, et al. JAMA Dermatol. 2022 Sep 1;158(9):997-1004. doi: 10.1001/jamadermatol.2022.2360. JAMA Dermatol. 2022. PMID: 35767240 Free PMC article.

References

REFERENCES

1. Goldblatt F, O'Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382(9894):797-808. doi:10.1016/s0140-6736(13)61499-3
1. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397(10281):1301-1315. doi:10.1016/s0140-6736(20)32549-6
1. Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590. doi:10.1136/bmj.m1590
1. Mehrmal S, Uppal P, Nedley N, Giesey RL, Delost GR. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: a systematic analysis from the global burden of disease study 2017. J Am Acad Dermatol. 2021;84(1):46-52. doi:10.1016/j.jaad.2020.04.139
1. Amanat M, Salehi M, Rezaei N. Neurological and psychiatric disorders in psoriasis. Rev Neurosci. 2018;29(7):805-813. doi:10.1515/revneuro-2017-0108

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Tumor necrosis factor-α inhibitor-associated psoriasis: Facts and hypotheses

Affiliations

Tumor necrosis factor-α inhibitor-associated psoriasis: Facts and hypotheses

Authors

Affiliations

Comment on

References

REFERENCES

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical